Bblythe

Antimicrobial Aficionado 💊 Infection Fighting Pharmacist 👩 Master of Pharmacy

[Bblythe @lsabeella]

Hope the staff at the hospital and my friends have a nice weekend🤔😘😊

[Bblythe @lsabeella]

At Gilead, we know there is much more work to be done, and our oncology corporate giving program is focused on health equity across the cancer care continuum.

[Gilead Sciences @GileadSciences]

We’re happy to share the great work being done at Sustained Health Initiatives of the Philippines to help end the #HIV epidemic. See the full story at https://t.co/xPAoe5CnTG #TogetherAgainstHIV

[Gilead Sciences @GileadSciences]

Today we announced an important update about our #COVID19 treatment and the #Omicron subvariants of concern, BA.4 and BA.5. https://t.co/KlckJNUJCh

[Gilead Sciences @GileadSciences]

Today we announced an agreement with Everest Medicines to transfer all development and commercialization rights to Gilead for one of our cancer therapies in Asia. Learn more. https://t.co/ebWyzXJgVS

[Gilead Sciences @GileadSciences]

We are pleased to announce new positive interim results from a Phase 3 study investigating our treatment in patients with HR+/HER2- metastatic breast cancer. Learn more. https://t.co/hxzkBNEync

[Gilead Sciences @GileadSciences]

We’ve ranked No. 1 in 10 indicators in the 2021 @PatientView Corporate Reputation of Pharma Patient Perspective: Hepatitis Edition, a report on perceptions of #hepatitis patient groups. The rankings motivate us to keep striving to help address the unmet needs of the community.

[Gilead Sciences @GileadSciences]

Senegal has had widespread #HIV prevention and treatment success over the past decade. When Fann Hospital faced its own barrier to patient care, see how one doctor — supported by Gilead — rebuilt the foundations of hope for his patients.

[Gilead Sciences @GileadSciences]

Following #AIDS2022, we connected with Jared Baeten, Gilead’s Vice President of HIV Clinical Development, to discuss top highlights from the conference and ways the company is looking to transform care and improve outcomes for people affected by #HIV.

[Gilead Sciences @GileadSciences]

We’re collaborating with @GLAAD, @HRC, @NBJCOnTheMove, @NCLRights & @NMACCommunity to address #monkeypox, which disproportionately affects the LGBTQ+ community. We're supporting education and a public policy response & creating an outbreak emergency fund: https://t.co/EbYQgLQ47f

[Gilead Sciences @GileadSciences]

The @BayAreaCouncil recently released a report showing the economic impact of our work. We believe strongly in investing in our local community, and we’ll continue contributing through philanthropy, environmental sustainability and further economic investment.

[Gilead Sciences @GileadSciences]

Organizations like @cesida_esp support people living with #HCV and #HIV and are crucial to addressing stigma and discrimination. Watch to find out more about how CESIDA is paving the way toward eliminating viral hepatitis by 2030.

[Gilead Sciences @GileadSciences]

Eleonora never gave up while facing non-Hodgkin lymphoma, and she credits CAR T-cell therapy for helping put her cancer in remission. Watch her inspiring story to learn how she advocated for her care.

[Gilead Sciences @GileadSciences]

The role of PrEP medicines is pivotal in helping to end the #HIV epidemic. We strive to work with partners to advance research efforts that acknowledge the needs of those disproportionately impacted by HIV and historically underrepresented in PrEP studies. #AIDS2022

[Gilead Sciences @GileadSciences]

Today we announced plans to acquire MiroBio, a UK-based company focused on discovering therapies to restore immune balance in autoimmune disease. The acquisition will complement our inflammation research and development strategy.

[Gilead Sciences @GileadSciences]

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) were recently updated for Breast Cancer. Learn more about what this means for clinicians and patients. https://t.co/M8te0DctPG

[Gilead Sciences @GileadSciences]

At #AIDS2022, we highlighted the efforts of our RADIAN community partners in Eastern Europe and Central Asia – and we’ll continue to share their inspiring stories. https://t.co/e86weGECuE

[Gilead Sciences @GileadSciences]

Person-centric approaches are at the heart of our scientific advancements at Gilead, and we’ve been honored to share our work at #AIDS2022. We’re dedicated to applying real-world learnings and insights to continue driving research that addresses unmet needs of the #HIV community.

[Gilead Sciences @GileadSciences]

We’re happy to welcome Deborah H. Telman to Gilead. She joins the company today as Executive Vice President, Corporate Affairs and General Counsel.

[Gilead Sciences @GileadSciences]

As #AIDS2022 wraps up, we’re reflecting on the progress made toward the ultimate goal of finding a functional cure for #HIV. We’re working to achieve that goal through collaboration and innovation.